Suppr超能文献

肺弹性和微血管形成作为儿童肺实变病因诊断的定量无创生物标志物(ELASMIC研究)

Lung Elastance and Microvascularization as Quantitative Non-Invasive Biomarkers for the Aetiological Diagnosis of Lung Consolidations in Children (ELASMIC Study).

作者信息

Huerta-Calpe Sergi, Guitart Carmina, Carrasco Josep Lluis, Salas Bárbara, Cambra Francisco José, Jordan Iolanda, Balaguer Mònica

机构信息

Paediatric Intensive Care Unit, Hospital Sant Joan de Déu, Universitat de Barcelona (UB), Passeig Sant Joan de Déu, 2, 08950 Barcelona, Spain.

Immunological and Respiratory Disorders in the Paediatric Critical Patient Research Group, Institut de Recerca Sant Joan de Déu (IRSJD), c. de Sta. Rosa, 39, 08950 Barcelona, Spain.

出版信息

Diagnostics (Basel). 2025 Apr 2;15(7):910. doi: 10.3390/diagnostics15070910.

Abstract

Acute lower respiratory tract conditions are highly prevalent in paediatrics. Many of these conditions present as consolidations on imaging studies. One of the most common causes is bacterial pneumonia (BP), which requires an accurate diagnosis to implement the best treatment plan. Despite the fact that major guidelines constrain the use of invasive tests, chest X-ray (CXR) or blood tests are still routinely used for the diagnosis. In this regard, the introduction of lung ultrasound (LUS) signified an advancement in reducing the invasiveness of diagnosis. However, there are still situations where distinguishing between different aetiologies remains challenging, especially in the case of atelectasis. This is a prospective cohort study to assess the diagnostic accuracy of new non-invasive, quantifiable, and reproducible imaging biomarkers (lung elastance and microvascularization ratio) for differentiating BP from another major entity that causes the appearance of consolidation in imaging tests, atelectasis. It will be conducted at Sant Joan de Déu Hospital in Spain from June 2025 to June 2027. Firstly, imaging biomarkers will be measured in well-aerated lung tissue without consolidation to establish their values in healthy lung tissue, according to a predefined imaging acquisition protocol. Subsequently, the imaging biomarkers will be assessed in patients with confirmed lung consolidation by LUS (Group 1: BP; Group 2: atelectasis). : The study aims to determine whether there are statistically significant differences in the biomarker values in relation to the normal values and between the different etiological groups. : The demonstration of the reliable diagnostic accuracy of these biomarkers could significantly reduce the need for invasive techniques and improve the therapeutic management of many patients with BP and other pulmonary conditions presenting with consolidation in imaging tests.

摘要

急性下呼吸道疾病在儿科中极为常见。其中许多疾病在影像学检查中表现为实变。最常见的病因之一是细菌性肺炎(BP),这需要准确诊断以实施最佳治疗方案。尽管主要指南限制了侵入性检查的使用,但胸部X线(CXR)或血液检查仍常规用于诊断。在这方面,肺部超声(LUS)的引入标志着在降低诊断侵入性方面取得了进展。然而,在某些情况下,区分不同病因仍然具有挑战性,尤其是在肺不张的情况下。这是一项前瞻性队列研究,旨在评估新的非侵入性、可量化且可重复的成像生物标志物(肺弹性和微血管化比率)在区分BP与另一种在影像学检查中导致实变表现的主要疾病——肺不张方面的诊断准确性。该研究将于2025年6月至2027年6月在西班牙圣琼·德乌医院进行。首先,将根据预定义的成像采集方案,在无实变的通气良好的肺组织中测量成像生物标志物,以确定其在健康肺组织中的值。随后,将通过LUS对确诊为肺实变的患者(第1组:BP;第2组:肺不张)进行成像生物标志物评估。:该研究旨在确定生物标志物值与正常值之间以及不同病因组之间是否存在统计学上的显著差异。:证明这些生物标志物具有可靠的诊断准确性,可显著减少对侵入性技术的需求,并改善许多BP患者以及在影像学检查中出现实变的其他肺部疾病患者的治疗管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af49/11988621/5f3a6f2ce595/diagnostics-15-00910-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验